Talking Points TCTMD
-
- Science
-
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
-
The ARIE-HM3 Trial
Mandeep Mehra and C. Michael Gibson discuss whether or not aspirin is needed for patients with left ventricular assist devices in advanced heart failure.
-
The AZALEA - TIMI Trial
Christian T. Ruff and C. Michael Gibson discuss the primary results of a randomized trial testing the efficacy of abelacimab versus rivaroxaban for stroke prevention in atrial fibrillation.
-
The heart-1 Trial of VERVE-101
Andrew Bellinger, Sek Kathiresan, and C. Michael Gibson talk about the phase 1b trial of what investigators hope may be a one-time genetic fix for hyperlipidemia.
-
Lepodisiran Phase I Trial
Steven Nissen and C. Michael Gibson discuss the efficacy and safety of lepodisiran, an extended duration short-interfering RNA meant to reduce lipoprotein (a).
-
CLEAR Outcomes Subanalysis
Paul Ridker and C. Michael Gibson discuss whether residual inflammatory risk or residual cholesterol risk is a more effective predictor of CV events among patients treated with statins.
-
The AXIOMATIC - SSP Trial
Mike Sharma and C. Michael Gibson discuss managing acute thromboembolic events in secondary stroke using antithrombotic treatment with factor XIa inhibition.